MktsMarkets

Arcturus Therapeutics Holdings Inc.
NASDAQ: ARCTKey statistics
ARCT News
Stories mentioning ARCT from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 2,061 | 7,197 | 17,151 | 28,301 | 29,382 | 22,766 | 41,673 | 49,859 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 21,527 | 24,475 | 23,265 | 29,579 | 34,893 | 43,780 | 39,134 | 58,669 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 30,992 | 38,503 | 33,663 | 39,917 | 46,208 | 56,160 | 52,410 | 70,985 |
| Operating Income (Loss) | (28,931) | (31,306) | (16,512) | (11,616) | (16,826) | (33,394) | (10,737) | (21,126) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 35.00 | 4,315 | 3,234 | 2,567 | (21.00) | 3,213 | 3,818 | 4,148 |
| Pretax Income | (29,083) | (13,448) | (9,176) | (14,076) | (30,010) | (7,120) | (17,366) | |
| Tax Provision | 4.00 | 0.00 | (5.00) | (217.00) | (150.00) | |||
| Net Income (Loss) | (26,964) | (29,079) | (13,448) | (9,180) | (14,076) | (30,005) | (6,903) | (17,216) |
| Earnings Per Share (Basic) | (0.95) | (1.06) | (0.49) | (0.34) | (0.52) | (1.11) | (0.26) | (0.64) |
| Earnings Per Share (Diluted) | (0.95) | (1.06) | (0.49) | (0.34) | (0.52) | (1.11) | (0.26) | (0.64) |
| Weighted Average Shares Outstanding (Basic) | 28,421 | 27,386 | 27,188 | 27,129 | 27,107 | 27,000 | 27,062 | 26,967 |
| Weighted Average Shares Outstanding (Diluted) | 28,421 | 27,386 | 27,188 | 27,129 | 27,107 | 27,000 | 27,062 | 26,967 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ARCT
Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) is a stock listed on the Nasdaq Stock Market under the ticker symbol ARCT. It last traded at $9.68 (Nov 2, 2026, 2:42 PM ET), down 12.2% on the day. That gives Arcturus Therapeutics a market capitalisation of $313.5M.
Over the past 52 weeks ARCT has traded between $5.50 and $17.96.
Revenue for the quarter ended Mar 31, 2026 was $2.1M; a net loss of $27.0M. Revenue was down 93.0% from $29.4M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $2.1M | -$27.0M | -1308.3% |
| Dec 31, 2025 | $7.2M | -$29.1M | -404.0% |
| Sep 30, 2025 | $17.2M | -$13.4M | -78.4% |
| Jun 30, 2025 | $28.3M | -$9.2M | -32.4% |
From Arcturus Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…